According to the Convention, the Contracting Parties undertake to elaborate a Pharmacopoeia which shall be common to the countries concerned and which shall be entitled "European Pharmacopoeia". The elaboration of the European Pharmacopoeia shall be undertaken by the Public Health Committee whose activities are carried on within the framework of the Council of Europe, in accordance with Resolution (59) 23 and the European Pharmacopoeia Commission established by the Public Health Committee for this purpose.
The Public Health Committee shall exercise a general oversight over the activities of the Commission and for this purpose the Commission shall submit a report on each of its sessions to the Public Health Committee.
All decisions taken by the Commission, other than those of a technical or procedural character, shall be subject to the approval of the Public Health Committee. If the Public Health Committee does not approve a decision or approves it only partially, the committee shall refer it back to the Commission for further consideration.
The Public Health Committee, having regard to the recommendations of the Commission under Article 6.d, shall fix the time limits within which decisions of a technical character relating to the European Pharmacopoeia shall be implemented within the territories of the Contracting Parties.
Committee members noted that annexing Ukraine to the abovementioned Convention will enable state regulatory bodies participate in the development of European quality standards in medicine and influence European policy in the sphere of medicine regulation.
The respective bill was registered under No.0277.